These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 15934840)
1. Versatility of gene therapy vectors through viruses. Barzon L; Stefani AL; Pacenti M; Palù G Expert Opin Biol Ther; 2005 May; 5(5):639-62. PubMed ID: 15934840 [TBL] [Abstract][Full Text] [Related]
2. Latest development in viral vectors for gene therapy. Lundstrom K Trends Biotechnol; 2003 Mar; 21(3):117-22. PubMed ID: 12628368 [TBL] [Abstract][Full Text] [Related]
3. Virus vector design in gene therapy. Günzburg WH; Salmons B Mol Med Today; 1995 Dec; 1(9):410-7. PubMed ID: 9415189 [TBL] [Abstract][Full Text] [Related]
4. Improvements in gene therapy: averting the immune response to adenoviral vectors. Ritter T; Lehmann M; Volk HD BioDrugs; 2002; 16(1):3-10. PubMed ID: 11908997 [TBL] [Abstract][Full Text] [Related]
5. Liposomal and viral vectors for gene therapy of the central nervous system. de Lima MC; da Cruz MT; Cardoso AL; Simoes S; de Almeida LP Curr Drug Targets CNS Neurol Disord; 2005 Aug; 4(4):453-65. PubMed ID: 16101560 [TBL] [Abstract][Full Text] [Related]
11. Invasive drug delivery. Blömer U; Ganser A; Scherr M Adv Exp Med Biol; 2002; 513():431-51. PubMed ID: 12575831 [TBL] [Abstract][Full Text] [Related]
12. Viral-mediated gene transfer for cancer treatment. Wilson DR Curr Pharm Biotechnol; 2002 Jun; 3(2):151-64. PubMed ID: 12022258 [TBL] [Abstract][Full Text] [Related]
13. AAV6 Vector Production and Purification for Muscle Gene Therapy. Halbert CL; Allen JM; Chamberlain JS Methods Mol Biol; 2018; 1687():257-266. PubMed ID: 29067669 [TBL] [Abstract][Full Text] [Related]